Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Sobre Lite Strategy

Fundada2018

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Comunidade
Twitter
Website
Etiquetas
Publicly listed company
Crypto Stocks

Tendência de mudança de índice em alta

Detalhes da arrecadação de fundos

Post-IPO(2025-07-21)
QuantiaR$516,19M
Valorização--